A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...

Submissions for the CV Team and CV Pharmacists Poster Sessions at ACC.25, taking place March 29-31, 2025, in Chicago, IL, are now open. All members of the cardiovascular team are invited to submit ...

There are several companies that are not affiliated with the American College of Cardiology that are posting registration and housing information for ACC.24. To protect your information, please only ...

There's still time to join your colleagues at the Valentin Fuster Cardiovascular Symposium, taking place Dec. 6-8 in Washington, DC. Explore sessions like: Evolving Strategies of Antithrombotic ...

Time is running out to showcase your expertise! JACC: Case Reports is seeking standout cases that highlight the critical role of multi-modality imaging in the diagnosis or intervention of complex ...

ACC Online Courses offer the cardiovascular community a collection of resources and newly developed, evidence-based educational activities across topics such as lipid management, valvular heart ...

What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...

The following are key points to remember from a state-of-the-art review on revisiting implantable cardioverter-defibrillator (ICD) therapy for primary prevention in patients with heart failure and ...

In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...

The following are key points to remember from a state-of-the-art review on cardiovascular (CV) risk in prostate cancer (PC): ...

The following are key points to remember from a European Society of Cardiology (ESC) clinical consensus statement on integration of genetic testing into diagnostic pathways for cardiomyopathies: ...

Based on the results from the MATTERHORN (A Multicenter, Randomized, Controlled Study to Assess Mitral Valve Reconstruction for Advanced Insufficiency of Functional or Ischemic Origin), transcatheter ...